GL1X · GenesisL1 explorer

MolNFT v1 · #86222 · protein

Co-crystal structure of wbdd and kinase inhibitor LY294002.

4AZT · Methyltransferase wbdd: “Co-crystal structure of wbdd and kinase inhibitor LY294002.”. X-ray diffraction, 4 ligands (SAM, LY2, SO4), 3 pockets (best druggability 0.66). MolNFT v1 #86222 on GenesisL1: 3D structure, binding sites and…

PDB
4AZT
Type
protein
Length
435 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Methyltransferase wbdd
UniProt
Q47592
Ligands
SAM, LY2, SO4, CL
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMethyltransferase wbddprotein43542% helix, 21% strandQ47592

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • LY2 · 2-morpholin-4-yl-7-phenyl-4H-chromen-4-one · ligand · chains A
  • SO4 · Sulfate ion · ion · 8 copies · chains A
  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12410.660.8336SAM
21940.560.7928LY2
3700.390.7921empty

Compared structures

  • 4AZT · Co-crystal structure of WbdD and kinase inhibitor LY294002. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q47592 · AlphaFold monomer V2.0 prediction for O-antigen chain terminator bifunctional… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.